L-arginine in the management of cardiovascular diseases

Citation
Jwm. Cheng et Sn. Balwin, L-arginine in the management of cardiovascular diseases, ANN PHARMAC, 35(6), 2001, pp. 755-764
Citations number
46
Categorie Soggetti
Pharmacology
Journal title
ANNALS OF PHARMACOTHERAPY
ISSN journal
10600280 → ACNP
Volume
35
Issue
6
Year of publication
2001
Pages
755 - 764
Database
ISI
SICI code
1060-0280(200106)35:6<755:LITMOC>2.0.ZU;2-S
Abstract
OBJECTIVE: TO examine the role of L-arginine in the management of cardiovas cular diseases. DATA SOURCES: A MEDLINE search (1966-April 2000) of review articles, using the search terms arginine, nitric oxide, and cardiovascular diseases, was c onducted. After reviewing these articles, primary studies using the search terms arginine, hypercholesterolemia, hypertension, diabetes, smoking, isch emic heart disease, and heart failure were reviewed. STUDY SELECTION: English-language human studies were selected and evaluated based on quality of review. DATA SYNTHESIS: Small-scale studies have demonstrated that intravenous L-ar ginine augments endothelial function by enhancing vasodilation and reducing monocyte adhesion. Oral supplementation demonstrated similar effects as we ll as improvement of exercise ability in patients with cardiovascular disea ses. CONCLUSIONS: L-arginine improves the management of multiple cardiovascular diseases. However, most published human studies are small. Before therapy c an be routinely recommended, larger, well-designed studies are required to confirm its effect.